Sufficient or not sufficient? That is the question. Recent UK and EPO case

Lunch time seminar by Joeeta Murphy, Senior Managing Attorney, and Dr. Alex Povey, Senior Attorney at Avidity IP.

The webinar will be specifically looking at the question of sufficiency between the UK and European Patent Office. Recently, the UK Supreme Court has handed down its judgment in patent dispute Regeneron Pharmaceuticals Inc v Kymab Ltd , making key rulings for the law of 'sufficiency'. The UKSC ruled that for a patent claim to a range of products to be sufficient, it must be possible for the skilled addressee of the patent (the 'skilled person') to make substantially all the types or embodiments of such products across the scope of the claim at the relevant date.

About Avidity IP

Founded in 1989, the Avidity business has developed into a highly respected organisation, servicing a diverse range of multi-national clients. Their professionals have years of experience in dealing with highly challenging, contentious patent cases; making Avidity IP renowned for its ability to successfully defend and enforce clients’ various IP rights.

Their services extend beyond typical intellectual property matters, focusing on commercial and strategic advice designed to help creators extract maximum value from their innovations. For more information, look at https://avidity-ip.com/.

About the speakers

Joeeta has over 20 years experience in the Patent and Trade Mark profession having worked in top tier private practice and as an in-house Attorney in a bio-pharmaceutical company. Joeeta is widely experienced in a variety of Life Sciences technologies such as small molecules, pharmaceuticals, biologicals, peptide, antibodies, stem cells, nucleic acid based therapeutics, siRNAs, collagen based implants, diagnostics and medical devises.

Alex has over 20 years’ experience in the patent profession as an in-house attorney at GSK and as a consultant at MSD, specialising in the drafting and prosecution of patent applications for small molecules, formulations, and pharmaceutical products.

Details:

Monday, Aug 24, 2020 12:00 pm | 1 hour | (UTC+01:00) Dublin, Edinburgh, Lisbon, London

Meeting number: 163 554 2152

Password: SBC123! (7221230 from phones and video systems)

https://stevenagebiosciencecatalyst.my.webex.com/stevenagebiosciencecatalyst.my/j.php?MTID=m18b973f6aace012e4be56c1a2db20a39

Join by video system

Dial 1635542152@webex.com

You can also dial 62.109.219.4 and enter your meeting number.

Join by phone

+44-20-7660-8149 United Kingdom Toll

Access code: 163 554 2152